Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,555 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06287944RecruitingPhase 1
Targeted radiation and chemo before donor stem cell transplant
This trial tests a new approach: giving a targeted radioactive antibody (attached to a drug that finds CD38 on cancer cells) along with low-dose chemotherapy and targeted radiation to the bone marrow before a donor stem cell transplant. The goal is to prepare the body for the transplant while killing remaining cancer cells more precisely.
Duarte, CaliforniaAges 18–70 - NCT06282718Recruiting
Observational study of respiratory infections in primary care
This study tracks how patients with respiratory infections (like bronchitis, sore throats, or COVID-19) are treated in family doctor offices across Europe. The goal is to learn more about these infections and improve care. You may be able to join if you have a cough, sore throat, or other symptoms that suggest a respiratory infection, and you go to a participating clinic.
AntwerpAges Any age - NCT06286709RecruitingPhase 2
Fecal transplant for PSC and colitis
This trial tests whether a fecal (stool) transplant from a healthy donor can help people with both PSC and inflammatory bowel disease. It aims to see if the treatment can improve liver health and reduce inflammation. You must have early to moderate liver scarring and be on stable medications.
BirminghamAges 18 years+ - NCT06290258RecruitingPhase 1/Phase 2
Fecal transplant for autism with stomach issues
This study tests if transplanting healthy bacteria into the gut can help children and young adults with autism who also have stomach problems. It aims to improve both digestive and behavioral symptoms.
Taoyuan CityAges 7–30 - NCT06291155RecruitingPhase 4
How SGLT2 inhibitors work in the kidneys for type 2 diabetes
This study tests how a drug called canagliflozin (an SGLT2 inhibitor) affects kidney function in people with type 2 diabetes. It involves two kidney biopsies to see how the drug works inside your kidneys, aiming to better protect kidney health.
Ann Arbor, MichiganAges 18–80 - NCT06291051Recruiting
Spinal cord stimulation for Parkinson's with painful bent spine
This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the back) is safe and can reduce pain and improve the forward-bent posture in people with Parkinson's disease. It is for those whose bent posture has not improved with standard medication and is causing significant pain.
AmiensAges 18 years+ - NCT06253650RecruitingPhase 2
Trastuzumab Deruxtecan for HER2-positive stomach cancer with remaining cancer after surgery
This trial tests if trastuzumab deruxtecan, a targeted drug, can help people with HER2-positive stomach or gastroesophageal junction cancer who still have cancer cells detected after surgery and chemotherapy. It aims to prevent the cancer from coming back.
MilanAges 18 years+ - NCT06265545Recruiting
Study for relapsed or hard-to-treat AML
This trial tests new treatment options for people whose acute myeloid leukemia (AML) has either not responded to standard therapy or returned. It aims to find better ways to help those who need new options.
TianjinAges Any age - NCT06261424Recruiting
Exercise program for spastic ataxia types ARSACS and SPG7
This study tests whether a supervised exercise program (including pool exercises) can help people with certain types of hereditary ataxia. The goal is to see if it reduces symptoms like muscle stiffness and coordination problems.
Baie-Saint-Paul, QuebecAges 16 years+ - NCT06253013Recruiting
CHARM-COPD program of care after a flare-up
This study tests a program of care called CHARM-COPD for people who recently left the hospital after a COPD flare-up. It offers virtual pulmonary rehab or remote monitoring to help you recover and manage your condition at home.
Toronto, OntarioAges 40 years+ - NCT06262282Enrolling by invitation
Phage therapy for stubborn NTM infection in cystic fibrosis
This trial tests whether a special virus therapy (phage) can help clear stubborn NTM lung infections in people with cystic fibrosis who have been on antibiotics for over a year without success. Participants will continue their antibiotics while receiving the phages.
Birmingham, AlabamaAges 6 years+ - NCT06263452RecruitingPhase 4
Beta-blockers and stress response study
This trial tests how beta-blockers affect your body's reaction to stress. You'll take a beta-blocker or placebo and then do a stress task, so researchers can measure inflammation and other responses.
Chapel Hill, North CarolinaAges 18–30 - NCT06257420Enrolling by invitation
Low-dose rapamycin for ME/CFS and Long-COVID
This trial tests whether a low dose of rapamycin, a drug that may help regulate the immune system, can improve symptoms in people with ME/CFS or Long-COVID.
Palo Alto, CaliforniaAges 18–65 - NCT06244199Recruiting
Transition to cardiac rehabilitation for veterans with heart disease
This study tests a program that helps Veterans with heart disease start cardiac rehabilitation (a supervised exercise and education program to improve heart health) while they are still in the hospital. It aims to overcome barriers like other health problems and frailty, and may add up to 2 days to your hospital stay.
Boston, MassachusettsAges 18 years+ - NCT06235632Enrolling by invitation
Selling to intoxicated customers: a study for Oregon stores
This study tests ways to help marijuana and alcohol stores in Oregon sell responsibly to customers who may be intoxicated. If you work at a store, you can join to help improve safety practices.
Golden, ColoradoAges 21 years+ - NCT06230718Recruiting
Thinking about moving your arm after stroke
This study tests if thinking about moving your arm (motor imagery) and watching a video of arm movements can help you move better after a stroke. It uses a technique called EMG to measure muscle signals while you try or imagine moving.
Salamanca, SalamancaAges 18–99 - NCT06237179RecruitingPhase 1/Phase 2
Exercise program to reduce heart risk in prostate cancer
This study tests whether a supervised exercise program can help reduce heart disease risk in men with prostate cancer who are on hormone therapy. Participants will exercise at home or in a group and be monitored for heart health changes.
Richmond, VirginiaAges 40–85 - NCT06233110RecruitingPhase 1
Ruxolitinib and fostamatinib for steroid-resistant chronic GVHD
This study tests two drugs, ruxolitinib and fostamatinib, together for people with chronic graft-versus-host disease (GVHD) that hasn't responded well to steroids. The goal is to see if this combination can better control GVHD.
Durham, North CarolinaAges 18–80 - NCT06230783Recruiting
Speech test for early Alzheimer's detection
This trial uses speech pattern analysis to detect early signs of Alzheimer's. If you're already in a Wisconsin Alzheimer's study, you may help test if your voice can reveal memory changes.
Madison, WisconsinAges 40–80 - NCT06237790Recruiting
Gene therapy versus cochlear implants for congenital hearing loss
This study looks at how well gene therapy or cochlear implants help restore hearing in people with severe hearing loss from birth. It compares the outcomes of these two treatments to see which is more effective.
Beijing, Beijing MunicipalityAges 6 months+ - NCT04565795Recruiting
Temporary dissolvable ureter stent after uncomplicated ureteroscopy
This trial studies a temporary stent that is designed to dissolve in the ureter after a straightforward ureteroscopy to remove a kidney/ureter stone. The goal is to check safety and how well the device performs, and whether it can replace longer-lasting stents for some people.
Phoenix, ArizonaAges 21–80 - NCT06223555Recruiting
Mixed meal energy study in healthy adults
This study looks at how your body responds to a mixed meal (a test drink or meal) when the calories are either fixed or adjusted to your energy needs. It may help researchers understand how to measure metabolism more accurately.
Phoenix, ArizonaAges 18–99 - NCT06207591Recruiting
Brain implant study for locked-in communication
This study tests a new brain implant (CortiCom) that may help people who are locked-in or nearly locked-in communicate again. It involves surgery to place the device in the brain and requires a caregiver and commitment to follow-up visits.
UtrechtAges 18–70 - NCT06210009Recruiting
Can a heart-healthy diet help prevent kidney stones?
This study tests whether a special diet (called DASH, similar to one for high blood pressure) can reduce substances in urine that cause kidney stones. If you have had kidney stones and live in the Birmingham area, this diet might help prevent future stones.
Birmingham, AlabamaAges 19–89
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,555 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.